HBV-Associated PAN — SCE Rheumatology MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: E — Antiviral therapy for hepatitis B combined with plasma exchange and short-course glucocorticoids
Hepatitis B-associated PAN requires a specific treatment approach distinct from idiopathic PAN. The strategy involves antiviral therapy to eradicate HBV (the underlying trigger) combined with short-course glucocorticoids to control the acute vasculitis and plasma exchange to remove circulating immune complexes. Prolonged immunosuppression should be avoided as it can promote viral replication. Successful HBV seroconversion typically leads to vasculitis remission. This differs from idiopathic PAN where more prolonged immunosuppression is appropriate.
Reference: Guillevin L et al 2005 HBV-PAN treatment; ACR 1990 PAN criteria